Key result
LLMs aid supervised heart failure workflow tasks, but retrospective evidence does not justify autonomous clinical care.
Why the study?
Artificial intelligence and large language models are being evaluated across the heart failure care pathway, but evidence maturity varies by task, requiring an appraisal to distinguish direct LLM evidence from other AI methods and establish a risk-based evaluation framework.
Answers are grounded in this paper and cite their sources.
Large language models can support clearly defined, supervised tasks in heart failure care such as EHR extraction, document drafting, patient information, and trial endpoint adjudication, but current evidence is predominantly retrospective and does not justify autonomous high-stakes care without human oversight.
Heart failure affects more than 64 million people worldwide and remains associated with high mortality and recurrent hospitalisation. Artificial intelligence (AI), including large language models (LLMs), is being evaluated across the care pathway, but evidence maturity varies by task. The aim of this narrative review was to appraise direct evidence for LLM applications in heart failure, distinguish it from supporting evidence for other AI methods and propose a risk-based framework for clinical evaluation and governance. The strongest direct LLM evidence concerns electronic health record extraction, document drafting, patient information and clinical trial endpoint adjudication. A small, randomised pilot evaluated supervised generative-AI-guided optimisation of guideline-directed medical therapy. Prospective case-finding and monitoring evidence largely concerns non-LLM AI. For conversational AI telemonitoring (a natural language interface with rule-based alerting), prospective evidence was limited to a single non-randomised controlled pilot. Performance depends on task definition, data completeness, human review and workflow adoption. Overall, LLMs can support clearly defined, supervised heart failure tasks, but current evidence does not justify autonomous high-stakes care. The evidence base is expanding but predominantly retrospective. Prospective trials, disease-specific benchmarks, equity assessment and regulatory engagement are prerequisites for safe clinical translation. Human oversight remains essential across all current-generation applications.
No takes yet. Share an insight, caveat, or question.
Devin et al. (2026) conducted a review in Heart failure. Artificial intelligence and large language models was evaluated. Large language models can support clearly defined, supervised heart failure tasks (e.g., EHR extraction, document drafting), but predominantly retrospective evidence does not justify autonomous care.
Synapse has enriched 10 related papers. Consider them for comparative context: